Drug recall · January 10, 2018
Midazolam Injection recall
Why: Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Midazolam Injection, USP, Preservative Free, 2 mg / 2 mL (1 mg / mL), 24 X 2mL Prefilled single-use syringes per carton, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 76045-001-20
- Lots / codes
Lot: 6400048
- Quantity
- 203136 syringes
- Company
- Fresenius Kabi USA, LLC, Wilson, NC
- Distribution
- Nationwide in the USA
- Initiated
- October 27, 2017 · Voluntary: Firm initiated
- Classified
- January 4, 2018
- Reported
- January 10, 2018
- Ended
- October 5, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Midazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.